Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_assertion type Assertion NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_head.
- NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_assertion description "[However, correcting for changes in neuron densities showed that hippocampal sclerosis patients had increased AMPA and NMDA mRNA levels per neuron compared with autopsies, and in the CA2 resistant sector GluR2 mRNA levels were numerically greater than autopsies and mass lesion cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_provenance.
- NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_assertion evidence source_evidence_literature NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_provenance.
- NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_assertion SIO_000772 9397013 NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_provenance.
- NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_assertion wasDerivedFrom befree-20140225 NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_provenance.
- NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_assertion wasGeneratedBy ECO_0000203 NP180529.RAr4icGW7W0bnVfiOUvgXW0O5MyQ_QW0DAUqRNySYGBCk130_provenance.